Intrinsic tumor subtypes can be determined using BluePrint, an 80-gene molecular subtyping test that classifies breast tumors as Basal-, Luminal- or HER2-type based on gene expression analysis [14]. This evidence concerns the gene ERBB2 and breast neoplasm.